Remove 2025 Remove Biotech Remove Strategic partnership
article thumbnail

Pharma & Biotech in 2025: The Top 6 Growth Opportunities Shaping the Future

Frost & Sullivan

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. Download our full analysis on the top 6 growth opportunities in pharma and biotech. Want deeper insights?

Biotech 52
article thumbnail

February 2025: Top 19 Medical Device Consultants, Professional Services, & Consulting Firms

Jake Jorgovan

Updated: February 2025 "Medicine is a science of uncertainty and an art of probability." - William Osler. Apotech Consulting: Is a trusted and dependable life science consulting organization, specializing in biotech and medtech sectors. They also focus on developing future care models and disruptive business strategies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 50 Technologies Shaping 2025: Innovations Redefining Growth & Investment

Frost & Sullivan

Join our upcoming Top 50 Technologies Growth Webinar to discover the key innovations that will drive growth, efficiency, and transformation in 2025 and beyond. Investment Outlook: Governments will mandate battery recycling , and automakers & energy companies will expand partnerships with recyclers.

Biotech 52
article thumbnail

Top 50 Technologies of 2025: Transforming Industries & Driving Strategic Investments

Frost & Sullivan

Join our upcoming Top 50 Technologies Growth Webinar to discover the key innovations that will drive growth, efficiency, and transformation in 2025 and beyond. Japan: Aiming for 10% SAF blending by 2030 , with Cosmo Energys large-scale green aviation fuel plant launching in 2025. Stay Ahead of the Curve Reserve Your Spot Now!

Biotech 52
article thumbnail

Southern Star Research Applauded by Frost & Sullivan for Delivering Comprehensive Clinical Trial Solutions and Its Competitive Strategies

Frost & Sullivan

13 th February 2025 Frost & Sullivan recently analyzed the biotechnology contract research organization (CRO) industry and, based on its findings, recognizes Southern Star Research with the 2024 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX.

Biotech 52
article thumbnail

Top 10 Transformations Impacting the Global Digital Surgery Industry

Frost & Sullivan

Companies must navigate regulatory challenges, leverage AI-driven innovations, and invest in strategic partnerships to stay competitive. The Road Ahead: Key Takeaways for Growth The global digital surgery market is evolving rapidly, driven by technological advancements and demographic shifts.

Biotech 52